Francis Lo
Known title: Chief People OfficerCIK: 0001780660
Associated companies
Transaction History
| ADPT | ▲ Buy | Option Exercise | 8,038 | $68K | 10/1/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 9,377 | $37K | 10/1/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 9,377 | $76K | 10/1/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 8,094 | $223K | 10/1/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 18,698 | $535K | 10/1/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 13,398 | $113K | 9/16/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 15,629 | $62K | 9/16/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 23,442 | $190K | 9/16/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 107,537 | $3.0M | 9/16/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 7,869 | $225K | 9/16/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 53,091 | $645K | 9/16/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 59,374 | $463K | 7/15/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 23,677 | $287K | 7/15/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 22,711 | $192K | 7/15/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 105,762 | $2.4M | 7/15/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 12,626 | $98K | 7/2/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 12,600 | $153K | 7/2/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 12,637 | $107K | 7/2/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 44,838 | $1.0M | 7/2/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 3,500 | $27K | 7/1/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 3,300 | $40K | 7/1/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 12,206 | $103K | 7/1/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 4,688 | $19K | 7/1/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,064 | $114K | 7/1/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 8,743 | $194K | 7/1/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 42,261 | $951K | 7/1/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 5,792 | $70K | 6/4/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 2,009 | $17K | 6/4/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 2,344 | $9K | 6/4/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 9,376 | $76K | 6/4/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 39,741 | $695K | 6/4/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 2,344 | $9K | 4/8/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 22,564 | $340K | 4/8/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 30,593 | $431K | 3/11/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 38,074 | $575K | 3/5/2026 | View on chart |
| ADPT | ▲ Buy | Grant | 44,063 | $0 | 3/4/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 36,650 | $286K | 1/12/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 7,723 | $94K | 1/12/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 21,002 | $178K | 1/12/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,215 | $57K | 1/12/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 79,590 | $1.4M | 1/12/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 3,125 | $50K | 1/2/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 3,125 | $12K | 1/2/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 4,394 | $77K | 12/22/2025 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 1,100 | $4K | 12/22/2025 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 1,100 | $9K | 12/22/2025 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 2,194 | $19K | 12/22/2025 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 37,750 | $294K | 12/15/2025 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 19,423 | $164K | 12/15/2025 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 39,849 | $159K | 12/15/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 113,890 | $1.8M | 12/15/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 7,085 | $49K | 3/5/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 13,790 | $96K | 3/5/2025 | View on chart |
| ADPT | ▲ Buy | Grant | 99,976 | $0 | 3/4/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 12,887 | $44K | 3/5/2024 | View on chart |
| ADPT | ▼ Sell | Open Market | 1,813 | $6K | 3/5/2024 | View on chart |
| ADPT | ▲ Buy | Grant | 99,976 | $0 | 3/4/2024 | View on chart |
| ADPT | ▼ Sell | Open Market | 6,816 | $58K | 3/6/2023 | View on chart |
| ADPT | ▲ Buy | Grant | 85,697 | $0 | 3/6/2023 | View on chart |
| ADPT | ▼ Sell | Open Market | 3,582 | $41K | 3/8/2022 | View on chart |
| ADPT | ▼ Sell | Open Market | 1,569 | $19K | 3/7/2022 | View on chart |
| ADPT | ▲ Buy | Grant | 74,135 | $0 | 3/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Adaptive Biotechnologies Fair Value Lifted on MRD Optimism
Adaptive Biotechnologies saw a modest increase in its fair value estimate driven by optimism regarding minimal residual disease (MRD) data. This development provides a fundamental reason for potential valuation adjustments, distinct from the technical indicators currently showing a negative divergence. The stock remains within its 52-week range, with analysts maintaining a higher average target price than the current market levels.
Adaptive Biotechnologies Fair Value Lifted on MRD Optimism. Adaptive Biotechnologies saw a modest increase in its fair value estimate driven by optimism regarding minimal residual disease (MRD) data. This development provides a fundamental reason for potential valuation adjustments, distinct from the technical indicators currently showing a negative divergence. The stock remains within its 52-week range, with analysts maintaining a higher average target price than the current market levels.